Concepedia

Anna Galstyan

AG

Statistics

Publications

13

Citations

829

H-Index

13

Active since

2016

Affiliations

Cedars-Sinai Medical Center(Current)

University of Regensburg

University of California, Irvine

Terasaki Foundation

California NanoSystems Institute

Anna Galstyan is an author at Cedars-Sinai Medical Center specializing in drug delivery, medicine, and blood-brain barrier permeability.

Publications per year

2016–2023

13

Publications

13

Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Anna Galstyan, Janet L. Markman, Ekaterina S. Shatalova et al. · Nature Communications · 2019 · 294 citations · Full text

Pharmacy, Immunology, Oncology +17

A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood–Brain Barrier

Liron L. Israel, Oliver Braubach, Anna Galstyan et al. · ACS Nano · 2019 · 85 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk

Tao Sun, Rameshwar Patil, Anna Galstyan et al. · Cancer Research · 2019 · 78 citations

Medicine, Cancer Biology, Oncology +17

Coarse particulate matter (PM2.5–10) in Los Angeles Basin air induces expression of inflammation and cancer biomarkers in rat brains

Julia Y. Ljubimova, Oliver Braubach, Rameshwar Patil et al. · Scientific Reports · 2018 · 75 citations · Full text

Public Health, Environmental Sciences, Toxicology +17

Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme

Szu‐Ting Chou, Rameshwar Patil, Anna Galstyan et al. · Journal of Controlled Release · 2016 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 13